In addition, systemic immunization of B16.OVA tumor-bearing mice with rMVA-Profilin controlled tumor growth and prolonged mouse survival comparable to that effect of systemic rMVA-CD40L (Fig. 3e, f). This evidence concerns the gene CD40LG and neoplasm.